Performance analysis of Soleno Therapeutics (SLNO)
Annual Return
Over the past 3 years, SLNO has had an average annual return of +130.33%, outperforming the benchmark SPY, which returned +19.99% annual.
Over the past 5 years, SLNO has had an average annual return of +30.18%, outperforming the benchmark SPY, which returned +12.93% annual.
Over the past 10 years, SLNO has had an average annual return of -3.56%, underperforming the benchmark SPY, which returned +15.02% annual.
Since Nov 13, 2014, SLNO has had an average annual return of -13.74%, underperforming the benchmark SPY, which returned +13.65% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +14.52% | +2.98% | +11.71% | +1,933.82% | -67.77% | -78.79% | -34.32% | +71.96% | -5.06% | -55.56% | -56.21% | +24.04% |
| 2014 | |||||||||||
| -61.56% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -16.72% | +1.36% | -14.30% | +57.69% | +0.39% | +14.52% | |||||||
| 2025 | +11.72% | -2.78% | +46.31% | +4.81% | -2.02% | +14.20% | +3.20% | -21.74% | -0.09% | -0.65% | -24.87% | -8.25% | +2.98% |
| 2024 | +15.18% | +4.21% | -11.39% | +4.35% | -5.80% | -3.04% | +18.19% | +1.51% | +3.15% | +9.05% | -4.28% | -14.69% | +11.71% |
| 2023 | +47.06% | -30.00% | +5.71% | +56.76% | +56.03% | -18.78% | +19.05% | -4.00% | +503.57% | -19.13% | +24.76% | +35.19% | +1,933.82% |
| 2022 | -13.27% | -8.74% | -31.14% | -10.43% | -19.42% | +14.46% | -7.37% | -13.64% | -25.00% | -40.35% | +8.82% | +83.78% | -67.77% |
| 2021 | +1.51% | +22.97% | -47.75% | -3.85% | -14.90% | +10.73% | -20.24% | +0.43% | +1.27% | -19.71% | -12.27% | -37.20% | -78.79% |
| 2020 | +17.76% | -19.67% | -14.38% | +28.12% | +10.18% | -33.95% | -22.47% | +24.35% | +17.32% | -30.68% | +12.60% | -1.49% | -34.32% |
| 2019 | +3.52% | -16.34% | +39.19% | -2.45% | +46.81% | -5.13% | -21.41% | -18.61% | -16.25% | +2.07% | +13.05% | +69.84% | +71.96% |
| 2018 | -1.72% | -5.04% | +7.97% | -8.45% | +25.58% | +12.19% | +15.84% | -22.55% | +2.87% | -3.23% | -7.61% | -11.46% | -5.06% |
| 2017 | +4.93% | -23.55% | +9.25% | -15.52% | +6.66% | -21.71% | -0.54% | +23.44% | -15.46% | -25.75% | -24.32% | +23.24% | -55.56% |
Drawdown analysis of Soleno Therapeutics (SLNO)
The maximum drawdown for the SLNO was -99.86%, occurring on Dec 8, 2022. This drawdown has not yet recovered.
The current SLNO drawdown is -91.92%.
Since Nov 13, 2014 SLNO has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.86% | Mar 4, 2015 | 1957 | Dec 8, 2022 | Ongoing | Ongoing | Ongoing |
| -70.79% | Nov 17, 2014 | 47 | Jan 27, 2015 | 16 | Feb 19, 2015 | 63 |
| -9.74% | Feb 26, 2015 | 1 | Feb 27, 2015 | 2 | Mar 3, 2015 | 3 |
| -8.34% | Feb 24, 2015 | 1 | Feb 25, 2015 | 1 | Feb 26, 2015 | 2 |
| -7.32% | Feb 19, 2015 | 1 | Feb 20, 2015 | 1 | Feb 23, 2015 | 2 |